Drugs / phIL12
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05077033 | Sep 2021 → Sep 2023 | basal cell carcinoma | Institute of Oncology Ljubljana | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | phIL12 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05077033 ↗ |
| Modality | Other / unclassified | “non-viral gene delivery method for plasmid DNA” NCT05077033 ↗ |
| Route | Other | “intratumoral phIL12 gene electrotransfer” NCT05077033 ↗ |